Damon Announces Plan to Resume Trading
VANCOUVER, BC, May 16, 2025 /PRNewswire/ – Damon Inc. (Nasdaq: DMN) (“Damon” or the “Company”), a designer and developer of electric... Read more.
NYSE Content Advisory: Pre-Market update + NYSE celebrates 233 years forward
NEW YORK, May 16, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s... Read more.
OPSWAT Opens New Cybersecurity Lab and Office in Arlington, VA
Critical infrastructure protection leader expands federal presence and national commitment to cybersecurity in the National Capital Region ARLINGTON, Va., May 16,... Read more.
Join AIC at Computex 2025 to Experience Breakthroughs in AI Storage and Computing
TAIPEI, Taiwan, May 16, 2025 /PRNewswire/ — AIC, a global leader in AI Storage and Computing solutions, is excited to announce its participation in Computex... Read more.
Victoria Friedman and Shawn Duckworth Join Convergence IP Law, Expanding IP Expertise at MaxVal Group, Inc.
LOS ALTOS, Calif., May 16, 2025 /PRNewswire/ — MaxVal Group, Inc. (“MaxVal”), a leading provider of intellectual property (IP) management solutions,... Read more.
Mudita Kompakt North America Optimized to Begin Shipping Next Week; Final Days for Special Pre-Order Pricing
WARSAW, Poland, May 16, 2025 /PRNewswire/ — Mudita, a mindful technology company from Poland, is excited to announce that its Mudita Kompakt (North America... Read more.
Whiskey Jypsi Names Tate Troelstrup as Chief Executive Officer
NASHVILLE, Tenn., May 16, 2025 /PRNewswire/ — Whiskey Jypsi, the fast-rising premium spirits brand known for its bold innovation and high-quality blends is... Read more.
Lamassu Biotech Collaborates With The Ohio State University To Study New Therapy For Man And Man’s Best Friend
Pioneering Research Will Help Drive Dual-Purpose Treatment for Life-Threatening Conditions in Both Humans and Man’s Best Friend CLEVELAND, May 16, 2025 /PRNewswire/... Read more.
Neurocrine Biosciences Presents Data Adding to the Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients with Tardive Dyskinesia
Patients Treated with INGREZZA® (valbenazine) Capsules Reported Continued Improvements in Functional and Health-Related Quality of Life Measures Findings Presented... Read more.
Lars Rebien Sørensen to join the board of directors of Novo Nordisk A/S
COPENHAGEN, Denmark, May 16, 2025 /PRNewswire/ — Novo Nordisk A/S announced earlier today that Lars Rebien Sørensen, Chair of the Novo Nordisk Foundation,... Read more.